pimavanserin
Showing 1 - 21 of 21
Parkinson Disease Trial (Pimavanserin)
Not yet recruiting
- Parkinson Disease
- Pimavanserin
- (no location specified)
Apr 3, 2023
Irritability Associated With Autism Spectrum Disorder Trial in United States (Pimavanserin)
Recruiting
- Irritability Associated With Autism Spectrum Disorder
- Pimavanserin
-
Phoenix, Arizona
- +3 more
Jan 10, 2023
Post-traumatic Stress Disorder, Insomnia Trial in Houston (Pimavanserin)
Completed
- Post-traumatic Stress Disorder
- Insomnia
- Pimavanserin
-
Houston, TexasMichael E. DeBakey VA Medical Center
Aug 10, 2022
Post-traumatic Stress Disorder, Insomnia Trial in Houston (pimavanserin, Placebo)
Not yet recruiting
- Post-traumatic Stress Disorder
- Insomnia
- pimavanserin
- Placebo
-
Houston, TexasMichael E. DeBakey VA Medical Center, Houston, TX
Jun 28, 2022
Insomnia Chronic, PTSD Trial in Houston (Pimavanserin)
Not yet recruiting
- Insomnia Chronic
- Posttraumatic Stress Disorder
- Pimavanserin
-
Houston, TexasMichael E. DeBakey VA Medical Center
Jun 14, 2022
Parkinson's Disease Psychosis, Dementia With Lewy Bodies Trial in San Antonio (Pimavanserin, Quetiapine)
Recruiting
- Parkinson's Disease Psychosis
- Dementia With Lewy Bodies
- Pimavanserin
- Quetiapine
-
San Antonio, TexasUT Health Science Center - San Antonio
Oct 18, 2022
Parkinson Disease Psychosis Trial in United States (Pimavanserin)
Completed
- Parkinson Disease Psychosis
- Pimavanserin
-
Scottsdale, Arizona
- +17 more
Aug 31, 2022
Neurodegenerative Diseases, Parkinson Disease, Parkinson Disease Psychosis Trial (Pimavanserin)
Recruiting
- Neurodegenerative Diseases
- +2 more
- Pimavanserin
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 24, 2023
Parkinson's Disease Trial in United States (Pimavanserin, Placebo, Quetiapine)
Terminated
- Parkinson's Disease
- Pimavanserin
- +2 more
-
Scottsdale, Arizona
- +15 more
Sep 21, 2021
Tourette Syndrome, Tardive Dyskinesia Trial in Houston (Pimavanserin)
Completed
- Tourette Syndrome
- Tardive Dyskinesia
- Pimavanserin
-
Houston, TexasBaylor College of Medicine
Mar 10, 2021
Adjunctive Treatment of MDD Trial in Worldwide (Pimavanserin)
Terminated
- Adjunctive Treatment of Major Depressive Disorder
- Pimavanserin
-
Garden Grove, California
- +70 more
Mar 31, 2022
Neuropsychiatric Symptoms Related to Neurodegenerative Disease Trial in Worldwide (Pimavanserin, Placebo)
Completed
- Neuropsychiatric Symptoms Related to Neurodegenerative Disease
- Pimavanserin
- Placebo
-
Gilbert, Arizona
- +103 more
Aug 12, 2022
Adjunctive Treatment of MDD Trial in Worldwide (Pimavanserin, Placebo)
Completed
- Adjunctive Treatment of Major Depressive Disorder
- Pimavanserin
- Placebo
-
Birmingham, Alabama
- +84 more
Oct 19, 2021
Schizophrenia Trial in Worldwide (Pimavanserin, Placebo)
Recruiting
- Schizophrenia
- Pimavanserin
- Placebo
-
Ciudad Autonoma Buenos Aires, Argentina
- +82 more
Oct 14, 2021
Treatment of Depression in Adults With Parkinson's Disease (PD) Trial in United States (Pimavanserin)
Completed
- Treatment of Depression in Adults With Parkinson's Disease (PD)
- Pimavanserin
-
Costa Mesa, California
- +20 more
Aug 14, 2020
Schizophrenia Trial in Worldwide (Pimavanserin)
Recruiting
- Schizophrenia
- Pimavanserin
-
Phoenix, Arizona
- +147 more
Oct 12, 2021
Agitation and Aggression in Alzheimer's Disease Trial in Worldwide (Pimavanserin)
Completed
- Agitation and Aggression in Alzheimer's Disease
- Pimavanserin
-
Costa Mesa, California
- +27 more
Apr 2, 2020
Adjunctive Treatment of MDD Trial in Worldwide (Pimavanserin, Placebo)
Completed
- Adjunctive Treatment of Major Depressive Disorder
- Pimavanserin
- Placebo
-
Helsinki, Finland
- +43 more
Jun 25, 2020
Adjunctive Treatment of MDD Trial in United States (Pimavanserin, Placebo)
Completed
- Adjunctive Treatment of Major Depressive Disorder
- Pimavanserin
- Placebo
-
Birmingham, Alabama
- +35 more
Oct 25, 2019